SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001194396-06-000239
Filing Date
2006-07-24
Accepted
2006-07-24 16:31:36
Documents
3

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D cpharm13d_66516.txt SC 13D 32635
2 JOINT FILING AGREEMENT cpharmex1_66516.txt EX-1 3011
3 SHARE PURCHASE AGREEMENT cpharmex2_66516.txt EX-2 106902
  Complete submission text file 0001194396-06-000239.txt   144697
Mailing Address 2 MERIDIAN ROAD TORONTO A6 M9W 4Z7
Business Address 2 MERIDIAN ROAD . TORONTO A6 M9W 4Z7
LORUS THERAPEUTICS INC (Subject) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0531
Type: SC 13D | Act: 34 | File No.: 005-49893 | Film No.: 06976833
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address GROSSFELD 10 ESCHEN N2 FL 9492
Business Address GROSSFELD 10 ESCHEN N2 FL 9492 423-79-17-066
ConPharm (Filed by) CIK: 0001369825 (see all company filings)

IRS No.: 000000000 | State of Incorp.: N2 | Fiscal Year End: 1231
Type: SC 13D